Samsung joined existing investor Takwin Labs to invest $7m in the real-time imaging technology developer, which is also a Microsoft accelerator graduate.

Novartis and Sanofi-Genzyme have co-led a first funding round for NeuroVia, which will use the cash to advance development of a drug for a rare genetic neurological disease.

Naver joined subsidiaries NHN Investment Corp and Line for a series A round announced at the same time as the launch of Syte.ai's clothing search platform.

Foxconn was among the investors in a $10.1m round that will support hiring, product development and production expansion, as Molekule releases its air purifier to the public.

Microsoft Ventures, which participated in the round's $10m first tranche in September, has returned to contribute to a $10m extension.

Salesforce Ventures and Workday Ventures both took part in a series A round that was disclosed alongside the launch of the app integration software developer's latest product.

Shandong Buchang Pharmaceuticals has taken part in a $17.7m round for Symbow Medical, which is working on a surgical navigation device.

The battle robot developer has secured $7.5m in a Qualcomm Ventures-backed round that will support commercialisation of its lead product, MekaMon.

Mayo Clinic, which co-launched artificial intelligence-equipped drug developer Qrative with AI software provider Nference, has also contributed to its $8.3m series A round.